PROCYSBI caps 75 mg fl 250 pce

7680671290028 CH-67129 A16AA04 07.99.0.

Reimbursement limitations:

PROCYSBI

L'utilisation de PROCYSBI doit se faire conformément aux données de l'information professionnelle approuvée par Swissmedic …

PROCYSBI caps 75 mg fl 250 pce
PROCYSBI caps 75 mg fl 250 pce
PROCYSBI caps 75 mg fl 250 pce
1 / 3
google

Details

Product number
6712902
CPT
-
Packaging group
250
Unit
Kapsel(n)
Composition
mercaptaminum 75 mg ut mercaptamini bitartras 258 mg, cellulosum microcristallinum, hypromellosum, natrii laurilsulfas, acidi methacrylici et ethylis acrylatis polymerisatum 1:1, triethylis citras, talcum, matériel de la capsule: gelatina, E 132, E 171, encre: lacca, propylenglycolum, natrii hydroxidum, povidonum, E 171, pro capsula corresp. natrium 0.16 mg.

Articles (1)

Procysbi 75 mg, gélules gastro-résistantes
Kapseln
250
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
03/06/2025
Patient information leaflet
Français
03/06/2025
Patient information leaflet
Italien
03/06/2025
Professional SmPC
Allemand
03/06/2025
Professional SmPC
Français
03/06/2025
Professional SmPC
Italien
03/06/2025

Detailed composition

Substance Quantity Type Category
(N/A)
75.0 MG Substance Wirkstoff (Principe actif)
(N/A)
258.0 MG Substance WIZUS
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
0.16 MG Substance HBESI

Reimbursement information

Public price
CHF 4492.40
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/07/2024

Authorization holder

Chiesi SA

1752 Villars-sur-Glâne

Authorization information

Swissmedic authorization number
67129
Drug name
Procysbi, gélules gastro-résistantes
Galenic form
KAHAM
ATC Code
A16AA04
Authorization status
Z
Dispensation category
B
First authorization
16/08/2019
Authorization expiration date
31/12/9999
IT number
07.99.0.
Domain
Human medicine

Packaging details

Description (FR)
PROCYSBI caps 75 mg fl 250 pce
Description (DE)
PROCYSBI Kaps 75 mg Fl 250 Stk
Market launch
16/08/2019
Narcotic (BTM)
No

Other packaging sizes

PROCYSBI caps 25 mg fl 60 pce
60 KAP
View